1 Product identity
Ingredient risk
No flagged ingredients
Histoplex
BrandBiotics Research Corporation→Other Combinations Capsule 14 ingredients DSLD #21844Net contents: 90 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-06-25
2 Ingredients (14)
IngredientGroupSafety
Proprietary BlendProprietary Blend (Combination)—
OshaOsha—
HesperidinHesperidin—
OliveOlive —
HydrangeaHydrangea—
Black WalnutBlack Walnut—
PicrorhizaPicrorhiza—
GelatinGelatin—
WaterWater—
GlycerinGlycerol—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Glycine — Limited Evidence
⚠ Well tolerated
Andrographis — Conditionally Safe
⚠ GI discomfort
⚠ Headache
Calcium — Limited Evidence
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Turkey Tail — Limited Evidence
⚠ GI effects
⚠ Immune stimulation
4 Label claims
• All Other
5 Data source
DSLD ID21844
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-06-25
6 More from Biotics Research Corporation
View Biotics Research Corporation Safety Scorecard → 240 products
5-HTP7-Keto-ZymeA.D.P.Acetyl-L-CarnitineADB5-PlusADHS7 Cite this page
Vancouver
Pkhakadze G. Histoplex — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 31]. Available from: https://supplement.ge/products/histoplex-21844/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG